Also phill, back in NVAX 3.84 +.42 on this: Rodman & Renshaw, LLC Announces Investment Opinion on Novavax, Inc. Monday December 5, 10:47 am ET Rodman & Renshaw, LLC Initiates Coverage of Novavax, Inc. With A Market Outperform Rating Analyst Sets 12 Month Target Price of $6.00